LanZhou Foci Pharmaceutical Co.,Ltd. (SHE:002644)

China flag China · Delayed Price · Currency is CNY
8.39
+0.17 (2.07%)
Apr 30, 2026, 3:04 PM CST
7.29%
Market Cap 4.28B
Revenue (ttm) 915.53M
Net Income (ttm) 49.21M
Shares Out 510.66M
EPS (ttm) 0.10
PE Ratio 87.03
Forward PE n/a
Dividend 0.02 (0.24%)
Ex-Dividend Date Jun 24, 2025
Volume 5,766,438
Average Volume 6,814,383
Open 8.19
Previous Close 8.22
Day's Range 8.19 - 8.47
52-Week Range 7.73 - 11.85
Beta 0.41
RSI 46.80
Earnings Date Apr 9, 2026

About SHE:002644

LanZhou Foci Pharmaceutical Co.,Ltd., research and development, production, and sales of traditional chinese medicines and health products in China. The company offers its products in various dosage forms, including pills, tablets, granules, capsules, and gelatin under the MingShan, BaoShu, BaoLu, and Foci brands. It also engages in planting and selling of Chinese medicinal materials; processing and selling of Chinese herbal medicine pieces; and production and sales of medical devices, such as protective masks. In addition, the company exports ... [Read more]

Sector Healthcare
Founded 1929
Employees 1,362
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002644
Full Company Profile

Financial Performance

In 2025, SHE:002644's revenue was 915.53 million, a decrease of -6.60% compared to the previous year's 980.23 million. Earnings were 49.21 million, a decrease of -18.08%.

Financial Statements

News

There is no news available yet.